These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 28733711)

  • 1. A brief history of neurological botulinum toxin therapy in Germany.
    Dressler D; Roggenkaemper P
    J Neural Transm (Vienna); 2017 Oct; 124(10):1217-1221. PubMed ID: 28733711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Botulinum toxin--the dose controls the poison. A historical sketch].
    Homann CN; Wenzel K; Kriechbaum N; Suppan K; Crevenna R; Ivanic G; Dressler D
    Nervenarzt; 2002 Jun; 73(6):519-24. PubMed ID: 12242998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botulinum toxin drugs: brief history and outlook.
    Dressler D
    J Neural Transm (Vienna); 2016 Mar; 123(3):277-9. PubMed ID: 26559824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From poison to remedy: the chequered history of botulinum toxin.
    Erbguth FJ
    J Neural Transm (Vienna); 2008; 115(4):559-65. PubMed ID: 17458494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Botulinum toxin: from drug to poison].
    Dressler D; Saberi FA
    Fortschr Neurol Psychiatr; 2009 Aug; 77 Suppl 1():S49-54. PubMed ID: 19685394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunological aspects of Botox, Dysport and Myobloc/NeuroBloc.
    Dressler D; Hallett M
    Eur J Neurol; 2006 Feb; 13 Suppl 1():11-5. PubMed ID: 16417592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Historical notes on botulism, Clostridium botulinum, botulinum toxin, and the idea of the therapeutic use of the toxin.
    Erbguth FJ
    Mov Disord; 2004 Mar; 19 Suppl 8():S2-6. PubMed ID: 15027048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. History of the clinical use of botulinum toxin A and B.
    Carruthers A
    Clin Dermatol; 2003; 21(6):469-72. PubMed ID: 14759577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The route of botulinum toxin from cause of food poisoning to medical remedy].
    Sätilä H
    Duodecim; 2014; 130(15):1523-30. PubMed ID: 25211822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Learning from the past: historical aspects of bacterial toxins as pharmaceuticals.
    Pellett S
    Curr Opin Microbiol; 2012 Jun; 15(3):292-9. PubMed ID: 22651975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beyond BOTOX: advantages and limitations of individual botulinum neurotoxins.
    Davletov B; Bajohrs M; Binz T
    Trends Neurosci; 2005 Aug; 28(8):446-52. PubMed ID: 15979165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Botulinum toxin for spasticity: a case for change to the Pharmaceutical Benefits Scheme.
    Datta Gupta A; Wilson DH
    Med J Aust; 2018 May; 208(9):379-381. PubMed ID: 29764344
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunological aspects of botulinum toxin therapy.
    Dressler D; Bigalke H
    Expert Rev Neurother; 2017 May; 17(5):487-494. PubMed ID: 27852103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical presentation and management of antibody-induced failure of botulinum toxin therapy.
    Dressler D
    Mov Disord; 2004 Mar; 19 Suppl 8():S92-S100. PubMed ID: 15027060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Historical note on the therapeutic use of botulinum toxin in neurological disorders.
    Erbguth FJ
    J Neurol Neurosurg Psychiatry; 1996 Feb; 60(2):151. PubMed ID: 8708643
    [No Abstract]   [Full Text] [Related]  

  • 16. The story of Clostridium botulinum: from food poisoning to Botox.
    Ting PT; Freiman A
    Clin Med (Lond); 2004; 4(3):258-61. PubMed ID: 15244362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of botulinum toxin to clinical therapy: advances and cautions.
    Levy NS; Lowenthal DT
    Am J Ther; 2012 Jul; 19(4):281-6. PubMed ID: 22481607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Botulinum toxin: from poison to drug. A historical review].
    Kreyden OP; Geiges ML; Böni R; Burg G
    Hautarzt; 2000 Oct; 51(10):733-7. PubMed ID: 11153358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Botulinum toxin type B de novo therapy of cervical dystonia: frequency of antibody induced therapy failure.
    Dressler D; Bigalke H
    J Neurol; 2005 Aug; 252(8):904-7. PubMed ID: 15761672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Botulinum toxin: structure, mode of action and therapeutic use].
    Tatarkiewicz J
    Postepy Hig Med Dosw; 1994; 48(5):505-20. PubMed ID: 7638099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.